Springer to test Europe with €2.5bn cov-lite

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Springer to test Europe with €2.5bn cov-lite

A €2.5bn-equivalent cov-lite loan backing the €3.3bn acquisition of German publisher Springer Science by private equity firm BC Partners is the latest opportunity for the European leveraged finance market to show how far it has recovered since the credit crisis and reveal just how competitive it is with the US market.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • European securitization issuance database
  • Daily newsletters across markets and asset classes
  • 1 weekly securitization podcast

Related articles

Gift this article